Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment

MG Mazza, M Palladini, S Poletti, F Benedetti - CNS drugs, 2022 - Springer
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic is still spreading worldwide
over 2 years since its outbreak. The psychopathological implications in COVID-19 survivors …

Onset and frequency of depression in post-COVID-19 syndrome: A systematic review

O Renaud-Charest, LMW Lui, S Eskander… - Journal of psychiatric …, 2021 - Elsevier
Following recovery from COVID-19, an increasing proportion of individuals have reported
the persistence and/or new onset of symptoms which collectively have been identified as …

Post-infection depressive, anxiety and post-traumatic stress symptoms: A prospective cohort study in patients with mild COVID-19

F Ismael, JCS Bizario, T Battagin, B Zaramella… - Progress in Neuro …, 2021 - Elsevier
Background It remains unclear whether COVID-19 is associated with psychiatric symptoms
during or after the acute illness phase. Being affected by the disease exposes the individual …

Covid-19 and promising solutions to combat symptoms of stress, anxiety and depression

D Vatansever, S Wang, BJ Sahakian - Neuropsychopharmacology, 2021 - nature.com
Time and research will be of the essence when deducing the longterm consequences of the
Covid-19 pandemic for global mental health and emotional well-being. Prior reports from …

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors

MG Mazza, R De Lorenzo, C Conte, S Poletti… - Brain, behavior, and …, 2020 - Elsevier
Infection-triggered perturbation of the immune system could induce psychopathology, and
psychiatric sequelae were observed after previous coronavirus outbreaks. The spreading of …

Depression and anxiety during the COVID-19 pandemic: epidemiology, mechanism, and treatment

C Zhu, T Zhang, Q Li, X Chen, K Wang - Neuroscience Bulletin, 2023 - Springer
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has had an adverse impact
on the physical and mental health of the public worldwide. In addition to illness in patients …

[HTML][HTML] Psychiatric sequelae in COVID-19 survivors: a narrative review

C Putri, J Arisa, JE Hananto, TI Hariyanto… - World Journal of …, 2021 - ncbi.nlm.nih.gov
In December 2019, a novel coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) was initially reported in Wuhan, China …

Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19

E Dąbrowska, B Galińska-Skok, N Waszkiewicz - Life, 2021 - mdpi.com
The dysfunctional effects of the coronavirus disease 2019 (COVID-19) infection on the
nervous system are established. The manifestation of neuropsychiatric symptoms during …

Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19

AYK Thye, JWF Law, LTH Tan, P Pusparajah, HL Ser… - Biology, 2022 - mdpi.com
Simple Summary The coronavirus can elude the immune response, potentially spreading to
cells other than the respiratory tract's epithelial cells. The neuro-invasive potential of certain …

Prevalence of depression and its association with quality of life in clinically stable patients with COVID-19

YF Ma, W Li, HB Deng, L Wang, Y Wang… - Journal of affective …, 2020 - Elsevier
Introduction High risk of mental health problems is associated with Coronavirus Disease
2019 (COVID-19). This study explored the prevalence of depressive symptoms (depression …